Condensed Consolidated Statements of Changes in Stockholders’ Equity (Unaudited) - USD ($)	Common Stock	Additional Paid-in Capital	Accumulated Deficit	Accumulated Other Comprehensive Income	Total
Balances at Dec. 31, 2021	$ 293	$ 126,583,738	$ (115,899,939)	$ 211,486	$ 10,895,578
Balances (in Shares) at Dec. 31, 2021	2,926,655
Stock-based compensation		4,499,107			4,499,107
Shares issued in lieu of interest	$ 1	251,006			251,007
Shares issued in lieu of interest (in Shares)	14,612
Warrants for services with the issuance of convertible debt		449,474			449,474
Cashless stock option exercise	$ 2	(2)
Cashless stock option exercise (in Shares)	23,139
Cashless warrant exercise
Cashless warrant exercise (in Shares)	172
Sale of common stock for cash, net of offering costs	$ 13	3,146,927			3,146,940
Sale of common stock for cash, net of offering costs (in Shares)	132,940
Common stock issued with convertible debt	$ 1	91,756			91,757
Common stock issued with convertible debt (in Shares)	3,562
Common stock issued for working capital facility	$ 1	302,999			303,000
Common stock issued for working capital facility (in Shares)	12,500
Net loss			(11,873,555)		(11,873,555)
Foreign currency translation				(35,048)	(35,048)
Balances at Jun. 30, 2022	$ 311	135,325,005	(127,773,494)	176,438	7,728,260
Balances (in Shares) at Jun. 30, 2022	3,113,580
Balances at Mar. 31, 2022	$ 310	132,441,881	(121,200,667)	244,226	11,485,750
Balances (in Shares) at Mar. 31, 2022	3,098,968
Stock-based compensation		2,632,118			2,632,118
Shares issued in lieu of interest	$ 1	251,006			251,007
Shares issued in lieu of interest (in Shares)	14,612
Net loss			(6,572,827)		(6,572,827)
Foreign currency translation				(67,788)	(67,788)
Balances at Jun. 30, 2022	$ 311	135,325,005	(127,773,494)	176,438	7,728,260
Balances (in Shares) at Jun. 30, 2022	3,113,580
Balances at Dec. 31, 2022	$ 318	140,257,448	(140,130,159)	155,929	283,536
Balances (in Shares) at Dec. 31, 2022	3,179,789
Stock-based compensation		1,895,711			1,895,711
Warrants issued for services		438,000			438,000
Shares issued in lieu of interest	$ 11	387,567			387,578
Shares issued in lieu of interest (in Shares)	111,516
Conversion of convertible notes into common stock	$ 235	15,331,776			15,332,011
Conversion of convertible notes into common stock (in Shares)	2,348,347
Conversion of credit facility borrowings into common stock	$ 24	899,976			900,000
Conversion of credit facility borrowings into common stock (in Shares)	245,634
Sale of common stock for cash, net of offering costs	$ 198	6,383,443			$ 6,383,641
Sale of common stock for cash, net of offering costs (in Shares)	1,989,676
Common stock issued for working capital facility (in Shares)					14,612
Net loss			(15,901,051)		$ (15,901,051)
Foreign currency translation				(156,137)	(156,137)
Balances at Jun. 30, 2023	$ 786	165,593,921	(156,031,210)	(208)	9,563,289
Balances (in Shares) at Jun. 30, 2023	7,874,962
Balances at Mar. 31, 2023	$ 325	141,319,889	(145,352,653)	131,863	(3,900,576)
Balances (in Shares) at Mar. 31, 2023	3,247,957
Stock-based compensation		1,055,690			1,055,690
Warrants issued for services		438,000			438,000
Shares issued in lieu of interest	$ 4	165,147			165,151
Shares issued in lieu of interest (in Shares)	43,348
Conversion of convertible notes into common stock	$ 235	15,331,776			15,332,011
Conversion of convertible notes into common stock (in Shares)	2,348,347
Conversion of credit facility borrowings into common stock	$ 24	899,976			900,000
Conversion of credit facility borrowings into common stock (in Shares)	245,634
Sale of common stock for cash, net of offering costs	$ 198	6,383,443			6,383,641
Sale of common stock for cash, net of offering costs (in Shares)	1,989,676
Net loss			(10,678,557)		(10,678,557)
Foreign currency translation				(132,071)	(132,071)
Balances at Jun. 30, 2023	$ 786	$ 165,593,921	$ (156,031,210)	$ (208)	$ 9,563,289
Balances (in Shares) at Jun. 30, 2023	7,874,962